• SCAI This Week
  • June 22, 2012

    In This Issue:





    Got What It Takes? ELM Seeking Tomorrow's Interventional Leaders

    Interested in becoming a future leader in the field of Interventional/Invasive Cardiology?

    Apply to participate in the ELM program this summer!

    SCAI's (Emerging Leader Mentorship) ELM Program in formal partnership with the American College of Cardiology (ACC) and the Cardiovascular Research Foundation (CRF) is charged with finding a small, highly selective group of up-and-coming physicians (up to 10 per two-year cycle) and facilitating their transition into the next generation of great thinkers, presenters, teachers and national leaders. 

    ELM Fellows participate in six training sessions over a two year period, timed with the SCAI, TCT and ACC annual conferences, and will be assigned a Mentor specifically chosen to match their interests and aspirations. Satellite sessions will explore other topics, such as dedicated leadership skill training and the role of industry.  They will also be assisted in identifying opportunities for committee service and faculty assignment with committee/program chairs at SCAI and partnering organizations. Identifying those opportunities congruent with their interests and developing niches, as well as opportunities to develop their own ideas and projects, will be a core goal of the ELM Program.

    More Information on Applying for the 2013-2015 ELM Program

    Catch Up With the 2011-2013 ELM Fellows

    View the List of 2011-2013 ELM Mentors

    Back to Top

    SCAI-QIT: Ten Tips to Improve Your Cath Lab's AUC Scores

    Improve your AUC scores with better communication, documentation, & coding. Share SCAI-QIT's Top-Ten Tips for Improving AUC Scores for Elective PCI with members of your cath lab team. SCAI is making it simple with the online posting of a color flier that can be downloaded, printed out and posted in the lab. SCAI will also be distributing a larger poster at its booth during upcoming cardiovascular meetings.

    Want to get more involved with SCAI-QIT? It's not too late to join the hundreds of other labs that have already signed up. Best yet, it's free. Sign up now!

    Download the Top-Ten Tips Flier

    Find Out More About SCAI-QIT

    Enlist to be a SCAI Quality Champion!


    The SCAI Quality Improvement Toolkit was originally developed with support from Daiichi Sankyo, Inc. and Lilly USA, LLC. This program is also supported by AstraZeneca. The Society gratefully acknowledges this support, while taking sole responsibility for all content developed and disseminated through this effort.

    Back to Top

    Are You Among SCAI's 700 Twitter Followers? Help Us Reach 800

    SCAI's Twitter account @SCAI passed 700 followers earlier this month and we're halfway to 800.

    Let's keep the momentum going. If you have a Twitter account, be sure to follow us @SCAI. If you tweet, please be sure to mention #SCAI programs or retweet @SCAI messages.

    Need something to promote to your patients? SCAI's @SECONDSCOUNTORG Twitter account is a great resource for your patients with the latest news and updates from SCAI's Patient Education Resource, www.SecondsCount.org.

    Spread the Word About #SCAI

    Want to share your favorite SCAI program with others? Perhaps it is SCAI-QIT, ELM, WIN, SCAI's eLearning Library, etc. Let the Twitter universe know about these programs and don't forget to use the hashtag #SCAI

    Back to Top

    SCAI Offering Newest Interventionalists 50% Off Membership

    SCAI wants to express its congratulations to all interventionalists-in-training who have completed their interventional cardiology fellowship training program!

    The Society recognizes this is an exciting time in your career, a time when opportunities may be plentiful but resources limited. It may also be the point in your career when you most need to be part of a community, a member of an organization whose members share your values and your goals and which is physician-led by doctors, for doctors.

    With that said, SCAI is offering 50% first year's dues for all new interventionalists!

    Details on This Offer & How It Can Help YOU Launch Your Career

    Back to Top

    Patients Sought for Phase III Stem Cell Trial for Chronic Refractory Angina

    The Renew Study is a phase III pivotal clinical trial to evaluate the efficacy and safety of adult autologous CD34+ stem cells to increase exercise capacity in patients with chronic myocardial ischemia (CMI) and refractory angina.

    The trial will enroll approximately 450 patients across 50 clinical sites in the United States, who will be randomized to one of three arms: treatment with their own autologous CD34+ stem cells, treatment with placebo (control), or unblinded standard of care. The primary objective is to evaluate the efficacy of treatment to improve the functional capacity of patients as measured by exercise tolerance testing. 

    To learn more or refer a patient please visit www.renewstudy.com or www.clinicaltrials.gov.

    Back to Top

    Miss SCAI 2012? On Demand Brings Vegas to You, Starting at Just $249

    Drawing record attendance and rave reviews, SCAI 2012 Scientific Sessions was IMPORTANT, INTENSE, INSPIRING, and a whole lot of FUN in Las Vegas. In other words, it was a can't-miss program.

    However, if you did miss it, you can still catch up with all the science, the debates, case reviews and clinical revelations with SCAI 2012 On Demand.

    Starting at just $249 for non-attendee members, SCAI 2012 On Demand captures all the educational content from SCAI 2012 Scientific Sessions*, bringing you multimedia re-creations with audio synchronized with slides which can be viewed from your PC or laptop or on your iPhone or iPad while you are on the go. Content will be available through May 1, 2013.

    Purchase SCAI 2012 On Demand Now!

    Download the iPhone/iPad SCAI 2012 App to View On Demand Content

    * SCAI can not guarantee 100% of sessions will be made available in SCAI 2012 On Demand

    Back to Top

    SCAI President Quoted on Limitations of AUC

    In a story on the new appropriate use criteria (AUC) for peripheral vascular testing, SCAI President J. Jeffrey Marshall, M.D., FSCAI, points out the limitations of appropriate use criteria. The AUC are becoming more important, he said, but the most important take-away “is that just because something is ‘uncertain’ does not mean it is inappropriate. We still don’t know everything in medicine. There still is some ‘art’ to medicine. . . . Clinical acumen is necessary in addition to having documents such as this to do the right procedure on the right patient at the right time.”

    Read the TCTMD Story

    Back to Top